KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Short term Debt (2016 - 2025)

Opko Health (OPK) has disclosed Short term Debt for 16 consecutive years, with $10.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short term Debt fell 30.97% year-over-year to $10.3 million, compared with a TTM value of $10.3 million through Dec 2025, down 30.97%, and an annual FY2025 reading of $10.3 million, down 30.97% over the prior year.
  • Short term Debt was $10.3 million for Q4 2025 at Opko Health, down from $12.8 million in the prior quarter.
  • Across five years, Short term Debt topped out at $30.1 million in Q3 2023 and bottomed at $62000.0 in Q4 2022.
  • Average Short term Debt over 5 years is $17.9 million, with a median of $17.6 million recorded in 2021.
  • The sharpest move saw Short term Debt plummeted 99.58% in 2022, then surged 43920.97% in 2023.
  • Year by year, Short term Debt stood at $14.7 million in 2021, then tumbled by 99.58% to $62000.0 in 2022, then soared by 43920.97% to $27.3 million in 2023, then crashed by 45.59% to $14.8 million in 2024, then crashed by 30.97% to $10.3 million in 2025.
  • Business Quant data shows Short term Debt for OPK at $10.3 million in Q4 2025, $12.8 million in Q3 2025, and $14.0 million in Q2 2025.